Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


General Pharmaceutical Council 

GPhC plans to publish inspections of registered pharmacies

Under the new rating model, registered pharmacies will have to meet all 26 standards or face public negative ratings and a mandatory improvement action plan.

Duncan Rudkin, GPhC chief executive

Source: General Pharmaceutical Council

Duncan Rudkin, chief executive of the GPhC, said the regulator had “learned a lot” from the current inspection model

The General Pharmaceutical Council (GPhC) is planning to publish its inspection reports, and issue simple ‘met’ or ‘not met’ ratings of pharmacies. 

It has also proposed that inspections will be unannounced “as a general rule in the future, to ensure the outcomes reflect whether the pharmacy is meeting the standards every day”.

The proposals are included in a draft consultation paper discussed at the GPhC council’s April meeting; it is expected that the consultation will officially launch before the summer.

In the draft consultation document, the GPhC proposes six key changes to its approach to regulating registered pharmacies, including the introduction of a new inspection model made up of three types of inspections: routine inspections, intelligence-led inspections and themed inspections.

The intelligence-led inspections will be conducted quickly in response to information received from others. Themed inspections will involve visiting a selection of pharmacies to focus on specific issues, in order to get a better understanding of issues, their causes and effects.

The GPhC proposes that there will only be two possible outcomes from an inspection — ‘met’ or ‘not met’; registered pharmacies must meet all 26 standards to get an overall ‘met’ outcome. If it is decided that the standards are not met, the pharmacy will be given a mandatory improvement action plan, the draft document says.

A significant change proposed in the draft document is the introduction of the publication of inspection reports, which will be made possible by the commencement of the Pharmacy (Premises Standards, Information Obligations, etc.) Order 2016, which the GPhC said it expected soon.

Papers presented to the GPhC council meeting say it has already begun work developing a new website where the public will be able to access inspection reports. Examples of notable practice identified through inspections will be held within a ‘knowledge hub’ on the website so it is “easy to search and analyse”.

“Our hope is that it will strengthen assurance for the public to be able to look at individual pharmacies and check on the public record that the pharmacy they are using is one that meets the standards,” said Duncan Rudkin, chief executive of the GPhC.

“By publishing information about individual pharmacies, as well as aggregated information, learning points and notable practice, we will provide an evidence base to support and encourage improvement across the sector,” he added.

The current inspection model has been operating since 2013 and, according to Rudkin, the GPhC will soon have inspected every pharmacy in the country against the standards for registered pharmacies.

He said the GPhC had “learned a lot” from the process, and he hoped that the pharmacy profession had too.

“It feels like it’s time to take stock to review how we can make inspection even more useful, to make it more transparent, to improve the accountability of pharmacy regulation and more importantly of pharmacy itself,” he said.

The draft consultation document says the council will expect to receive an analysis report from the consultation in the second part of 2018 and, following that, a report will be published detailing the GPhC’s decision on how it plans to proceed.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20204713

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Workplace Drug Testing

    Workplace Drug Testing

    Explains drug testing regulatory frameworks and all aspects of drug analysis. Case studies of successful programmes are included.

    £81.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.